About Duke Rohlen
Form D filings for XII Medical from 2022 to 2024 list Duke Rohlen as director.
Duke Rohlen first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Duke Rohlen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Duke Rohlen works with at each company, as listed on that company's latest Form D.
XII Medical, Inc. · Form D, Aug 30, 2024
GS
Garrett Schwab
Chief Executive Officer and director
JF
Jd Friedland
Director
SH
Saoussen Ben Halima
Director
SK
Shane Kreidel
Secretary and Chief Financial Officer
RG
Raman Gowri
Director
TN
Tony Natale
Director
DG
Daniel Gottlieb
Director